BDTBOTCServices-Management Consulting ServicesFiscal year ends September 30
Bodhi Tree Biotechnology Inc
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.28+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $7.17M
- P/E (TTM)
- –
- Dividend yield
- –
Bodhi Tree Biotechnology statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Management Consulting Services companies for comparison
Valuation
| Measure | Bodhi Tree Biotechnology | Industry median |
|---|---|---|
| Market Cap | $7.17M | $73.61M |
| Enterprise Value | $7.17M | $55.54M |
| PS Ratio | 193.90 | 3.25 |
| PB Ratio | 519.02 | 3.13 |
| P/TBV Ratio | 519.02 | 8.30 |
Enterprise value
| Measure | Bodhi Tree Biotechnology | Industry median |
|---|---|---|
| EV / Sales | 193.79 | 2.79 |
Income (trailing twelve months)
| Measure | Bodhi Tree Biotechnology | Industry median |
|---|---|---|
| Revenue | $37.00K | $24.74M |
| Operating Income | -$114.77K | -$55.64K |
| Pretax Income | -$114.76K | $45.62K |
| Net Income | -$116.03K | -$97.64K |
| EBITDA | -$114.77K | -$29.48K |
| EPS (Diluted) | -$0.01 | $0.00 |
Margins
| Measure | Bodhi Tree Biotechnology | Industry median |
|---|---|---|
| Operating Margin | -310.2% | 0.94% |
| Pretax Margin | -310.2% | 2.64% |
| Profit Margin | -313.6% | 0.51% |
| EBITDA Margin | -310.2% | 3.48% |
Returns
| Measure | Bodhi Tree Biotechnology | Industry median |
|---|---|---|
| Return on Equity (ROE) | -161.5% | 0.45% |
| Return on Assets (ROA) | -156.6% | -3.47% |
| Return on Invested Capital (ROIC) | -899.0% | 2.85% |
| Return on Capital Employed (ROCE) | -830.2% | 2.03% |
Balance sheet
| Measure | Bodhi Tree Biotechnology | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $3.99K | $5.43M |
| Net Cash (Debt) | $3.99K | $17.62K |
| Net Cash Per Share | $0.00 | $0.00 |
| Equity (Book Value) | $13.82K | $10.50M |
| Book Value Per Share | $0.00 | $0.60 |
| Tangible Book Value | $13.82K | -$78.36K |
Financial position
| Measure | Bodhi Tree Biotechnology | Industry median |
|---|---|---|
| Quick Ratio | 0.89 | 0.65 |
Cash flow (trailing twelve months)
| Measure | Bodhi Tree Biotechnology | Industry median |
|---|---|---|
| Operating Cash Flow | -$115.53K | $8.04K |
Efficiency
| Measure | Bodhi Tree Biotechnology | Industry median |
|---|---|---|
| Asset Turnover | 0.50 | 0.83 |
Dividends and yields
| Measure | Bodhi Tree Biotechnology | Industry median |
|---|---|---|
| Earnings Yield | -1.62% | -1.29% |
Shares
| Measure | Bodhi Tree Biotechnology | Industry median |
|---|---|---|
| Shares Outstanding | 25,441,000 | 29,217,800 |
| Shares Change (QoQ) | 0.00% | 0.00% |
| Float | 25,441,000 | 26,226,050 |
| Shares Held by Insiders | 0.00% | 4.85% |
Scores
| Measure | Bodhi Tree Biotechnology | Industry median |
|---|---|---|
| Altman Z-Score | 913.72 | 2.64 |
Calculated by StockData from Bodhi Tree Biotechnology's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.